PPIB and Hepatitis: Nearly all subjects in each group achieved seroprotective antibody concentration (≥10 mIU/ml) against hepatitis B surface antigen (98.5, 99.5 and 100.0 %, respectively) after hepatitis B vaccination at birth and 3-dose primary series (Table 2).